http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6040187-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fca31e40a2462d93d4c37babd7834834
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aef66f841fb3b2a4b1a4486ea7cf0d5b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-689
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5091
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
filingDate 1995-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2000-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09daa3c4d68eb92c3e8e69e072a11ed2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3df77020e3def57ff0ac0e672c30061f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fa659dcc2f539e9d51dd8ce827e3b30
publicationDate 2000-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6040187-A
titleOfInvention Method of determining the suppressor cell component of human immune status and a means for the realization thereof
abstract The method for determining a suppressor component of human immune status comprises collecting peripheral blood, obtaining a suspension of mononuclear cells (MNCs), dividing said suspension into two equal portions, cultivating MNCs in the first portion without a suppressor activator, cultivating MNCs in the second portion with said suppressor activator (TBG), washing MNCs out of culture medium, blocking the proliferation, adding newly isolated MNCs from a normal donor, which MNCs have been stimulated with phytohemagglutinin, into each of MNC portions in equal proportions to obtain test cultures, cultivating said test cultures, further evaluating the proliferation in said test cultures and determining the suppression value on the basis of the ratios of proliferation levels in test cultures.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011086020-A1
priorityDate 1994-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8801875-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CH-676467-A5
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9110443-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5013719-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2650183-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2170707-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5141849-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4275000-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1061818-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5169835-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5118669-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1657190-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8805297-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395874
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395875
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5746
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID231224

Total number of triples: 43.